Pharmaceutical White Papers
Download the latest White Papers
A Vaccinne Bioassay Case Study – A Successful Strategic Outsourcing Model
February-2010
Increasingly, pharma and biotech firms are searching for new drivers of revenue and profit growth. There are a number of trends and forces within the pharmaceutical industry that are causing companies to rethink their approaches to growth and cost management. To find out more, please download this free white paper.
Animal Models of Relapsing-Remitting Multiple Sclerosis
February-2010
Relapsing-Remitting Experimental Autoimmune Encephalomyelitis (RR-EAE) is an animal model that mimics the initial courses of multiple sclerosis in humans. A rat model of RR-EAE is available at Neurofit. This model responds positively to anti-inflammatory / immunosuppressant drugs such as dexamethasone. For more information, please download this free white paper.
Absorption of Lisinopril Solution versus Tablets in Healthy Volunteers
February-2010
A single-dose, randomised, crossover study comparing the main pharmacokinetic characteristics and bioavailability profile of a new formulation of lisinopril solution with that of a commercially available tablet formulation.
Avoid Headaches: Grundfos Sanitary Pumps for Industrial Pharmaceutical Applications
February-2010
Grundfos sanitary pumps are manufactured and certified to meet the highest industry standards to ensure the reliable supply of WFI water so crucial in pharmaceutical production. With our solutions you know your product's integrity is guaranteed and its level of quality reproduced every time. This white paper outlines details, production standards and design features of our pumps for pharmaceutical applications.
Anti-Psychotic Drug-Induced Dysphoria
January-2010
Whi le dysphoria is a well-recognised reaction in healthy volunteers, it is probably insufficiently recognised in patients, particularly if it occurs in hte absence of akathisia. Better detection could improve compliance in patients.
A Study of the Psychomotor and Cognitive Impairments Produced by Diazepam as Measured by NES 2
January-2010
Harris Laboratories purchased the Neurobehavioural Evaluation System (NES 2) in 1991 with the intention of establishing a psychomotor function testing unit. An automated microcomputer based system, NES 2 was initially designed to assess the effects of environmental exposure to potentially toxic substances on psychomotor and cognitive function.
Animal Models of Cognitive Dysfunction
January-2010
Three instrumental in-vivo assays for assessing the efficiency of drugs for the treatment of cognitive deficits are available at Neurofit. These assays can also be used to assess the side effect of drugs on memory (safety pharmacology).
Automating Training Control Processes to Comply with FDA Requirements
November-2009
Well-managed training programs minimize the risk of non-compliance and improve product quality. This presentation discusses the challenges of not having automated training control processes, and the colossal benefits of having such processes to manage and track the hundreds to thousands of job functions that require employee training.
Adaptive Trial Design
October-2009
This free Cmed white paper explores how adaptive methodologies are playing an increasing role in the development of medical solutions.
Activity Mart for Complete Test Results Management
July-2009
Identify potential drug candidates faster and more accurately
Additional Products and Services
June-2009
We offer accredited practice-related and 'hands-on' seminars/workshops
PrevNext
Delicious
Digg
Reddit
Stumble
Facebook
LinkedIn